According to the latest regulatory filing, Insecticides India reported a significant decline in profitability for the quarter ended June 2026. The company's consolidated net profit fell 24.5% year-on-year to ₹44 crore compared to ₹58.10 crore in the corresponding quarter of the previous year. The substantial profit decline was primarily attributed to deficient rainfall across India that impacted near-term revenue performance during the quarter. The earnings conference call for these results was held on August 11, 2026, with the audio recording made available on the company's website pursuant to Regulation 30 read with Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
As reported by the latest regulatory filing, the company's total income declined 11.5% to ₹611.5 crore in Q1 FY2027 compared to ₹691.1 crore in the same quarter of the previous year. The revenue contraction was primarily attributed to a rainfall deficit across India, which significantly impacted agricultural demand for the company's products. Despite the revenue decline, the company managed to improve its gross margin through disciplined pricing actions. The company's total turnover for FY26 stood at ₹2,140 crore, providing context for the quarterly performance against the full-year baseline.
According to the latest financial data, the company's gross profit margin expanded to 31.6% from 29.2%, an improvement of 240 basis points, supported by disciplined pricing actions. However, EBITDA fell 20% year-on-year to ₹67.6 crore from ₹84.5 crore, while EBITDA margin stood at 11.1% compared with 12.2% in Q1 FY26. The company's profit before tax declined to ₹58.82 crore, impacted by higher finance costs and depreciation charges, leading to the significant drop in bottom-line profitability. The earnings release highlighted that while gross margins improved, operating leverage eroded as expenses rose, indicating the inability to pass efficiencies to the EBITDA level. As per The Economic Times, EBITDA contracted to ₹659 million from ₹840 million, with EBITDA margin narrowing to 10.90% from 12.15%, reflecting the combined impact of lower revenues and a relatively less flexible cost base.
During the quarter, Insecticides India launched GRANUVIA, a next-generation insecticide, across India in collaboration with Corteva Agriscience, as reported by CNBC TV18. The company also introduced Spinoace as part of the collaboration. The company executed a pan-India mega launch of GRANUVIA, supported by extensive engagement with distributors, dealers, and farmers. The company's KAEROS brand continued its strong trajectory, expanding its portfolio and distribution footprint while reinforcing its position as a strategic growth lever. High-impact farmer outreach efforts included over 3,600 farmer meetings, 600 field days, 1,400 demonstrations, and more than 15,000 farmer visits in Q1FY27.
As reported by NDTV Profit, Insecticides India shares were trading at a downturn of 1.82% to ₹637.95 at 3:09 p.m., compared to a 0.52 downturn of the NSE Nifty 50. The stock opened at ₹649.65, compared to its previous close of ₹649.80, with trading range between ₹603.35 to ₹655.65 during the session. Looking at its last 52-week performance, the stock has touched a low of ₹518.60 and a high of ₹1,058.80. On the performance front, Insecticides (India) Ltd. share price is down 35.11% on a year-on-year basis. The company's market capitalization stands at ₹2,235.44 crore with a P/E ratio of 13.45. Managing Director Rajesh Kumar Aggarwal stated that deficient rainfall impacted near-term revenue, while pricing discipline and operating efficiencies helped maintain stability in gross margins. The expansion in gross margin suggests effective premiumization strategies, likely supported by the Focus Maharatna and Maharatna portfolios.
